AI

Bayer and Exscientia will initially work on three early-stage projects using AI to speed up drug discovery.

The AI system was able to reduce the percentage of false negative mammograms by 5.7% in the US and 1.2% in the UK. 

physIQ Director of Clinical Development Karen Larimer details her company's work to extract raw sensor readings from sensors and highlights the takeaways for clinicians.

There are a handful of recent academic projects employing algorithms, says Vuno Medical Director Hyunho Park, who describes how similar technologies are making the jump into care.

Melinda Wassell, chief health informatics officer at Work Healthy Australia, says helping practitioners improve patient outcomes through data dashboards also benefits employers with better risk mitigation strategies.

Scale Venture Partners headed the round, which comes roughly a year and a half after OM1's $21 million Series B.